Should Low Molecular Weight PSMA Targeted Ligands Get Bigger and Use Albumin Ligands for PSMA Targeting?

Prostate Specific Membrane Antigen (PSMA) is strongly expressed in prostate cancer. Recently a number of low-molecular-weight inhibitors have demonstrated excellent PSMA targeting activity for both imaging as well as Lutecium-177 radiotherapy in human trials. The paper by Choy et al raises the quest...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Steve S., Heston, Warren D.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479280/
https://www.ncbi.nlm.nih.gov/pubmed/28638479
http://dx.doi.org/10.7150/thno.20284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479280/
https://www.ncbi.nlm.nih.gov/pubmed/28638479
http://dx.doi.org/10.7150/thno.20284

Ejemplares similares